benzotriazole has been researched along with casein kinase ii in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bretner, M; Duncan, JS; Graves, LM; Gyenis, L; Haystead, TA; Lenehan, J; Litchfield, DW | 1 |
| Bretner, M; Kilanowicz, A; Muszyńska, G; Najda-Bernatowicz, A; Sapota, A; Łebska, M | 1 |
| Bain, J; Cozza, G; Di Maira, G; Elliott, M; Kazimierczuk, Z; Meggio, F; Orzeszko, A; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S | 1 |
| Bretner, M; Kopańska, K; Krzywińska, E; Muszyńska, G; Najda-Bernatowicz, A; Orzeszko, A; Łebska, M | 1 |
| Kabachinski, G; Klenchin, VA; Loyet, KM; Martin, TF; Nojiri, M | 1 |
| Poznański, J; Shugar, D; Wąsik, R; Wińska, P | 1 |
| Kucińska, K; Makowska, M; Poznański, J; Shugar, D; Winiewska, M | 1 |
| Bugajska, E; Poznański, J; Winiewska, M | 1 |
| Bretner, M; Chojnacki, K; Skierka, K; Wielechowska, M; Wińska, P | 1 |
| Bretner, M; Chojnacki, K; Niefind, K; Tölzer, C; Wielechowska, M; Wińska, P; Łukowska-Chojnacka, E | 1 |
| Marzec, E; Paprocki, D; Poznański, J | 1 |
| Bretner, M; Kasperowicz, S; Maciejewska, AM; Marzec, E; Mieczkowska, K; Poznański, J; Trzybiński, D; Woźniak, K | 1 |
12 other study(ies) available for benzotriazole and casein kinase ii
| Article | Year |
|---|---|
An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.
Topics: Benzimidazoles; Casein Kinase II; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Inhibitory Concentration 50; Kinetics; Models, Chemical; Mutation; Proteomics; Triazoles; Tumor Suppressor Proteins | 2008 |
New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole.
Topics: Benzimidazoles; Casein Kinase II; Humans; Protein Kinase Inhibitors; Triazoles | 2008 |
The selectivity of inhibitors of protein kinase CK2: an update.
Topics: Animals; Benzimidazoles; Casein Kinase II; Humans; Indazoles; Jurkat Cells; Kinetics; Models, Molecular; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship; Triazoles | 2008 |
Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Topics: Benzimidazoles; Casein Kinase II; Humans; Phthalimides; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2009 |
CAPS activity in priming vesicle exocytosis requires CK2 phosphorylation.
Topics: Amino Acid Sequence; Animals; Calcium; Calcium-Binding Proteins; Casein Kinase II; Chlorocebus aethiops; COS Cells; Exocytosis; Humans; Mice; Molecular Sequence Data; PC12 Cells; Phosphorylation; Rats; Sequence Homology, Amino Acid; Serine; Triazoles | 2009 |
Synthesis and physico-chemical properties in aqueous medium of all possible isomeric bromo analogues of benzo-1H-triazole, potential inhibitors of protein kinases.
Topics: Bromine; Casein Kinase II; Isomerism; Protein Kinase Inhibitors; Solubility; Thermodynamics; Triazoles; Water | 2012 |
Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2α.
Topics: Binding Sites; Calorimetry; Casein Kinase II; Halogenation; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Protein Kinase Inhibitors; Static Electricity; Thermodynamics; Triazoles | 2015 |
ITC-derived binding affinity may be biased due to titrant (nano)-aggregation. Binding of halogenated benzotriazoles to the catalytic domain of human protein kinase CK2.
Topics: Binding Sites; Calorimetry; Casein Kinase II; Catalytic Domain; Halogenation; Humans; Ligands; Molecular Structure; Protein Binding; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Spectrum Analysis; Thermodynamics; Triazoles | 2017 |
Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
Topics: Antineoplastic Agents; Benzimidazoles; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2017 |
Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Topics: Benzimidazoles; Binding Sites; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Humans; Molecular Dynamics Simulation; Phosphorylation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-pim-1; Recombinant Proteins; Structure-Activity Relationship; Triazoles | 2018 |
Thermodynamic contribution of iodine atom to the binding of heterogeneously polyhalogenated benzotriazoles by the catalytic subunit of human protein kinase CK2.
Topics: Casein Kinase II; Catalytic Domain; Humans; Iodine; Magnetic Resonance Spectroscopy; Thermodynamics; Triazoles | 2020 |
A competition between hydrophobic and electrostatic interactions in protein-ligand systems. Binding of heterogeneously halogenated benzotriazoles by the catalytic subunit of human protein kinase CK2.
Topics: Casein Kinase II; Catalytic Domain; Crystallography, X-Ray; Humans; Hydrocarbons, Halogenated; Hydrophobic and Hydrophilic Interactions; Ligands; Protein Kinase Inhibitors; Static Electricity; Structure-Activity Relationship; Triazoles | 2020 |